Gufic Biosciences Ltd

GUFICBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,831 cr, stock is ranked 757
High RiskStock is 3.26x as volatile as Nifty
188.902.80 (-1.46%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,831 cr, stock is ranked 757
High RiskStock is 3.26x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
41.40
PB RatioPB Ratio
10.56
Dividend YieldDiv. Yield
0.05%
Sector PESector PE
38.07
Sector PBSector PB
5.10
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Gufic Biosciences Limited manufactures pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Formulations, Bulk Drugs and Consumer.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021310.03354.94384.63491.4316.4821.9422.7044.23
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 9.73%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.11%

See detailed holdings

Recent EventsAll events 

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnNov 16, 2021

Gufic Biosciences Limited has informed the Exchange about Transcript | Download

Gufic Biosciences Limited has informed the Exchange about Transcript | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnNov 10, 2021

Gufic Biosciences Limited has informed the Exchange about Link of Recording | Download

Gufic Biosciences Limited has informed the Exchange about Link of Recording | Download

Cash Dividend 
Ex. DateSep 9, 2021

Final • Div/Share: ₹ 0.1

See all events